IP Library Granted Patent US 12698466
Granted Patent B2
US 12698466 · App. 17/413,885 · Granted Aug 4, 2026

Nanoparticles based method for screening enzyme or microorganism

Inventors: Wenbing Du (Beijing, CN); Yuxin Qiao (Beijing, CN); Dongwei Chen (Beijing, CN); Shufang Zhao (Beijing, CN); Ming Li (Beijing, CN); Ying Zhang (Beijing, CN); Wanghui Xu (Beijing, CN); Cheng Peng (Beijing, CN); Beiyu Hu (Beijing, CN); Ran Hu (Beijing, CN)
Assignees: Novozymes A/S; Institute of Microbiology, Chinese Academy of Sciences
C12M23/16C12Q1/37B82Y5/00C40B30/08
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12698466
App. No.
17/413,885
Granted
Aug 4, 2026
Kind
B2
Abstract

A nanoparticle comprises water-insoluble polymer matrix and an indicator constituent(s), wherein the indicator constituent(s) is released from the nanoparticle only when the polymer matrix is degraded or broken, and then an indicative effect is triggered or enhanced. A nanoparticle-based method for screening a bioactive substance and a microfluidic-based screening system have also been disclosed.

Claims (20)

1 . A method for screening a bioactive substance of a library which is capable of degrading or assisting in degrading a water-insoluble polymer matrix using a microfluidic-based system, said method comprising:

a) generating a first droplet containing a bioactive substance;

b) coalescing a secondary droplet containing a nanoparticle with the droplet generated in step a);

wherein the nanoparticle comprises water-insoluble polymer matrix encapsulating an indicator constituent, and wherein the indicator constituent is released from the nanoparticle only when the polymer matrix is degraded or broken; and wherein the nanoparticle is formed by providing a solution comprising one or more polymers, and then contacting the solution with a polymer nonsolvent to produce the nanoparticle;

c) sorting the droplets in step b) based on an indicative effect generated by the indicator constituent, and

d) analyzing the sorted droplets to screen for the bioactive substance;

wherein the bioactive substance is a water-insoluble polymer degrading enzyme or a water-insoluble polymer degrading microorganism.

2 . The screening method according to claim 1 , wherein, when the indicative effect of a droplet reaches or is above a preset threshold level, the droplet is selected.

3 . The screening method according to claim 1 , wherein the droplet sorting is based on a fluorescence activated droplet sorting technique.

4 . The screening method according to claim 1 , wherein water-insoluble polymer degrading enzyme is a hydrolase, isomerase, ligase, lyase, oxidoreductase, or transferase.

5 . The screening method according to claim 1 , further comprises a droplet incubation process, wherein the droplet containing the bioactive substance is incubated.

6 . The screening method according to claim 1 , wherein each droplet before sorting comprises at most a single cell.

7 . The screening method according to claim 1 , wherein the library is a microorganism library comprising a multitude of different microorganism, wherein the amount of indicative effect released by microorganism reaches or is above the predetermined threshold level, whereby a targeted enzyme or a targeted microorganism is identified.

8 . The screening method according to claim 1 , wherein the bioactive substance library is an enzyme library comprising a multitude of enzyme variants derived from a parent enzyme, wherein an increased amount of indicative effect has been released by the active enzyme variant, as compared with the parent enzyme, whereby an improved enzyme variant is identified.

9 . The screening method according to claim 1 , wherein the water-insoluble polymer matrix is degraded or broken, from which the indicator constituent is released, and then an indicative effect is triggered or enhanced.

10 . The screening method according to claim 1 , wherein the water-insoluble polymer matrix comprises or consists of an enzyme substrate.

11 . The screening method according to claim 1 , wherein the water-insoluble polymer is polyester, starch, saccharides, lipids, lignin, protein, nucleic acid, amylose, cellulose, pectin, chitin, fatty acids, lignin, alginate acid, hyaluronic acid, agar, mannan, xanthan gum, arabic gum, protein, DNA or RNA.

12 . The screening method according to claim 1 , wherein the water-insoluble polymer is polybutylene terephthalate (PBT), polypropylene terephthalate (PTT), polyethylene terephthalate (PEN), polyethylene terephthalate, tetramethylene terephthalate (PTMT), polyethylene-4-oxybenzoate, polyethylene glycol, polyvinyl chloride, polyglycolic acid, polylactic acid, polyanhydride, polycaprolactone, polyacrylonitrile, polypropylene, or polyvinyl alcohol.

13 . The screening method according to claim 1 , wherein the indicator constituent is a fluorogenic indicator.

14 . The screening method according to claim 1 , wherein both the polymer matrix and indicator constituent can be degraded or hydrolyzed by a specific active enzyme, and then, the indicative effect is triggered or enhanced.